We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+7.28%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$38.3B
AUM Growth
+$3.74B
Cap. Flow
+$1.7B
Cap. Flow %
4.44%
Top 10 Hldgs %
48.94%
Holding
2,327
New
317
Increased
1,057
Reduced
555
Closed
188

Sector Composition

Rank Sector Weight
1 Technology 5.73%
2 Financials 3.33%
3 Consumer Discretionary 2.25%
4 Healthcare 1.77%
5 Communication Services 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAIL icon
1476
Cambria Tail Risk ETF
TAIL
$145M
$274K ﹤0.01%
+12,684
New +$277K
INSG icon
1477
Inseego
INSG
$108M
$273K ﹤0.01%
2,641
-568
-18% -$65.6K
KBE icon
1478
State Street SPDR S&P Bank ETF
KBE
$1.64B
$273K ﹤0.01%
+9,269
New +$288K
SNV
1479
DELISTED
Synovus
SNV
$272K ﹤0.01%
+12,863
New +$268K
STK
1480
Columbia Seligman Premium Technology Growth Fund
STK
$837M
$272K ﹤0.01%
+12,414
New +$278K
FTK icon
1481
Flotek Industries
FTK
$935M
$271K ﹤0.01%
16,691
HLT icon
1482
Hilton Worldwide
HLT
$74B
$271K ﹤0.01%
3,176
-3,890
-55% -$325K
PRK icon
1483
Park National Corp
PRK
$3.41B
$271K ﹤0.01%
3,308
+40
+1% +$3.25K
CBAY
1484
DELISTED
Cymabay Therapeutics
CBAY
$271K ﹤0.01%
+37,365
New +$200K
SDC
1485
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$271K ﹤0.01%
23,200
+1,008
+5% +$9.26K
FEX icon
1486
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.58B
$270K ﹤0.01%
+4,274
New +$268K
LRCX icon
1487
CALL
Lam Research
LRCX
$382B
$270K ﹤0.01%
+200,000
New +$6.89M
ARKK icon
1488
CALL
ARK Innovation ETF
ARKK
$5.89B
$269K ﹤0.01%
13,300
-4,700
-26% -$402K
FATE icon
1489
Fate Therapeutics
FATE
$281M
$269K ﹤0.01%
6,734
-983
-13% -$34.3K
NEO icon
1490
NeoGenomics
NEO
$1.81B
$269K ﹤0.01%
+7,301
New +$271K
PSEC icon
1491
Prospect Capital
PSEC
$1.06B
$269K ﹤0.01%
53,566
-4,104
-7% -$20.6K
RACE icon
1492
Ferrari
RACE
$63.3B
$269K ﹤0.01%
1,459
+115
+9% +$21.4K
BBH icon
1493
VanEck Biotech ETF
BBH
$396M
$268K ﹤0.01%
1,651
+372
+29% +$60.5K
NVRI icon
1494
Enviri
NVRI
$621M
$268K ﹤0.01%
19,247
ADX icon
1495
Adams Diversified Equity Fund
ADX
$3.17B
$267K ﹤0.01%
16,471
+745
+5% +$11.9K
R icon
1496
Ryder
R
$10.3B
$267K ﹤0.01%
6,322
+130
+2% +$5.26K
BAC.PRL icon
1497
Bank of America Series L
BAC.PRL
$3.95B
$266K ﹤0.01%
179
+14
+8% +$20.5K
PWV icon
1498
Invesco Large Cap Value ETF
PWV
$1.66B
$266K ﹤0.01%
7,825
+658
+9% +$22.6K
PXH icon
1499
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.9B
$265K ﹤0.01%
15,095
+2,515
+20% +$46.1K
BCS icon
1500
Barclays
BCS
$94.1B
$264K ﹤0.01%
52,724
+7,402
+16% +$40.9K

Similar funds

Creative Planning's Q3 2020 Portfolio in Review

As of Q3 2020, Creative Planning held 2,327 positions worth $38.3B, up 11% from $34.6B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Creative Planning deployed $1.7B of net new capital in Q3 2020, opening 317 new positions and adding to 1,057 existing holdings. Its largest new stake was iShares 10-20 Year Treasury Bond ETF: 87,009 shares worth $14.5M.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 5.2% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $76.4M trimmed.

  • Creative Planning's largest Q3 2020 buy was iShares 10-20 Year Treasury Bond ETF: 87,009 shares worth $14.5M.
  • Creative Planning added most to Vanguard Total Bond Market in Q3 2020, an estimated $513M increase.
  • Creative Planning's biggest Q3 2020 reduction was Vanguard Total Stock Market ETF, cutting an estimated $76.4M.
  • Creative Planning fully exited Nuveen ESG US Aggregate Bond ETF in Q3 2020, selling an estimated $2.34M.
  • Creative Planning's ten largest holdings make up 49% of its $38.3B portfolio in Q3 2020.
  • Creative Planning opened 317 new positions and closed 188 in Q3 2020.
  • Creative Planning's portfolio value rose 11% quarter-over-quarter to $38.3B.

Based on Creative Planning's 13F filing for Q3 2020, filed 5 Nov 2020.